Our Approach

Ardelyx develops:

  • Innovative, non-systemic, small molecule therapeutics that work exclusively in the GI tract to treat cardio-renal, GI and metabolic diseases.
  • We have developed a proprietary drug discovery and design platform enabling us, in a rapid and cost-efficient manner, to discover and design novel drug candidates

Targeted Therapeutic Areas

Ardelyx has established a unique approach to drug development with programs targeting gut transporters, receptors, and enzymes

Therapeutic Areas

Investors

CMEA Capital –www.cmea.com
New Enterprise Associates –www.nea.com
Amgen Ventures – http://www.amgen.com/partners/amgen_ventures.html

Frequently Asked Questions

When was Ardelyx founded?
Ardelyx was founded in 2007.

Where is Ardelyx incorporated?
Ardelyx was incorporated in the state of Delaware in October 2007.

Where is Ardelyx’ corporate headquarters?
34175 Ardenwood Boulevard Suite 100
Fremont, CA 94555
Phone: (510) 745-1700

Whom can I contact if I am a member of the media?
For media inquiries, please send an email to media@ardelyx.com.